PharmAthene to Present at Rodman & Renshaw Annual Global Investment Conference

PharmAthene to Present at Rodman & Renshaw Annual Global Investment Conference

PR Newswire

ANNAPOLIS, Md., Sept. 3, 2013

ANNAPOLIS, Md., Sept. 3, 2013 /PRNewswire/ --PharmAthene, Inc. (NYSE MKT:
PIP), a biodefense company developing medical countermeasures against
biological and chemical threats, announced today that Eric I. Richman,
President and Chief Executive Officer will present at the Rodman & Renshaw
Annual Global Investment Conference on Monday, September 9, 2013 at 10:25 a.m.
EDT in Room 7.03, 7^th Floor of the Millennium Broadway Hotel, New York.

Event:  Rodman & Renshaw Annual Global Investment Conference
Date: Monday, September 9, 2013
Place: Millennium Broadway Hotel, New York, NY
Time:  10:25 am EDT

About PharmAthene

PharmAthene was formed to meet the critical needs of the United States and its
allies by developing and commercializing medical countermeasures against
biological and chemical threats. PharmAthene's current biodefense portfolio
includes the following product candidates:

  oSparVax^® - a next generation recombinant protective antigen (rPA) anthrax
    vaccine
  oRecombinant BChE - a novel bioscavenger for the prevention and treatment
    of morbidity associated with exposure to chemical nerve agents
  oValortim^® - a fully human monoclonal antibody for the prevention and
    treatment of anthrax infection

In addition, in May 2013, the Delaware Supreme Court issued its ruling on the
appeal in our litigation with SIGA Technologies, affirming the Court of
Chancery's finding that SIGA was liable for breach of contract, reversing its
finding of promissory estoppel, and remanding the case back to the Court of
Chancery to reconsider the appropriate remedy and award of attorney's fees and
expert witness costs in light of the Supreme Court's opinion. For more
information about PharmAthene, please visit www.PharmAthene.com.

SOURCE PharmAthene, Inc.

Website: http://www.pharmathene.com
Contact: Stacey Jurchison, PharmAthene, Inc., (410) 269-2610,
Stacey.Jurchison@PharmAthene.com